{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T18:06:40Z","timestamp":1772734000669,"version":"3.50.1"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,5]]},"abstract":"<jats:p>This scientific commentary refers to \u2018Haematopoietic stem cell transplant versus immune-reconstitution therapy in relapsing multiple sclerosis\u2019 by Kalincik et al. (https:\/\/doi.org\/10.1093\/brain\/awaf286).<\/jats:p>","DOI":"10.1093\/brain\/awag044","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T12:37:21Z","timestamp":1769863041000},"page":"704-706","source":"Crossref","is-referenced-by-count":0,"title":["A tight match: comparing the effectiveness of immune reconstitution therapies for multiple sclerosis"],"prefix":"10.1093","volume":"149","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3822-1218","authenticated-orcid":false,"given":"Paolo A","family":"Muraro","sequence":"first","affiliation":[{"name":"Department of Brain Sciences, Imperial College London , London W12 0NN ,","place":["UK"]},{"name":"Imperial College Healthcare NHS Trust , London ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"De Matteis","sequence":"additional","affiliation":[{"name":"Department of Brain Sciences, Imperial College London , London W12 0NN ,","place":["UK"]},{"name":"Imperial College Healthcare NHS Trust , London ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7757-0293","authenticated-orcid":false,"given":"Antonio","family":"Scalfari","sequence":"additional","affiliation":[{"name":"Department of Brain Sciences, Imperial College London , London W12 0NN ,","place":["UK"]},{"name":"Imperial College Healthcare NHS Trust , London ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"2026030512071846400_awag044-B1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41582-024-01050-x","article-title":"Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder\u2014Recommendations from ECTRIMS and the EBMT","volume":"21","author":"Muraro","year":"2025","journal-title":"Nat Rev Neurol."},{"key":"2026030512071846400_awag044-B2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.2018.18743","article-title":"Effect of nonmyeloablative hematopoietic stem cell transplantation vs continued disease-modifying therapy on disease progression in patients with relapsing-remitting multiple sclerosis: A randomized clinical trial","volume":"321","author":"Burt","year":"2019","journal-title":"JAMA"},{"key":"2026030512071846400_awag044-B3","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/brain\/awaf286","article-title":"Haematopoietic stem cell transplant versus immune-reconstitution therapy in relapsing multiple sclerosis","volume":"149","author":"Kalincik","year":"2026","journal-title":"Brain"},{"key":"2026030512071846400_awag044-B4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/jnnp-2020-323992","article-title":"Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing-remitting multiple sclerosis: An observational study","volume":"92","author":"Zhukovsky","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2026030512071846400_awag044-B5","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1111\/ene.14324","article-title":"Aggressive multiple sclerosis: A single-centre, real-world treatment experience with autologous haematopoietic stem cell transplantation and alemtuzumab","volume":"27","author":"Boffa","year":"2020","journal-title":"Eur J Neurol"},{"key":"2026030512071846400_awag044-B6","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/ana.27247","article-title":"Effectiveness of autologous hematopoietic stem cell transplantation versus alemtuzumab and ocrelizumab in relapsing multiple sclerosis: A single center cohort study","volume":"98","author":"Muraro","year":"2025","journal-title":"Ann Neurol"},{"key":"2026030512071846400_awag044-B7","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1001\/jamaneurol.2016.5867","article-title":"Long-term outcomes after autologous hematopoietic stem cell transplantation for multiple sclerosis","volume":"74","author":"Muraro","year":"2017","journal-title":"JAMA Neurol."},{"key":"2026030512071846400_awag044-B8","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1136\/jnnp-2024-335512","article-title":"Factors associated with outcomes following autologous haematopoietic stem cell transplantation for multiple sclerosis","volume":"96","author":"Noui","year":"2025","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"2026030512071846400_awag044-B9","first-page":"146","article-title":"Real-world effectiveness of autologous haematopoietic stem cell transplantation for multiple sclerosis in the UK","volume":"97","author":"Muraro","year":"2026","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2026030512071846400_awag044-B10","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1001\/jamaneurol.2023.1184","article-title":"Comparative effectiveness of autologous hematopoietic stem cell transplant vs fingolimod, natalizumab, and ocrelizumab in highly active relapsing-remitting multiple sclerosis","volume":"80","author":"Kalincik","year":"2023","journal-title":"JAMA Neurol"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/brain\/advance-article-pdf\/doi\/10.1093\/brain\/awag044\/66716722\/awag044.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/149\/3\/704\/66716722\/awag044.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/149\/3\/704\/66716722\/awag044.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T17:07:23Z","timestamp":1772730443000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/149\/3\/704\/8455756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":10,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,2,3]]},"published-print":{"date-parts":[[2026,3,5]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awag044","relation":{},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2026,2,3]]}}}